A critical advance in cancer investigation is arising with the use of mini-antibodies to reactivate mutated p53. This crucial cancer protector protein is frequently lost in several types of malignancies, leading https://socialnetworkadsinfo.com/story23689671/nanobodies-reactivate-p53-new-promising-pathway-for-cancer-therapy